Peptide Libraray

T11F

General Information

DCTPep ID DCTPep01827

Peptide Name T11F

Sequence TCRVDHRGLTF

Sequence Length 11

UniProt ID Not available

PubChem CID 71598136

Origin AMPs

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C55H89N19O16S1

Absent amino acids AEIKMNPQSWY

Theoretical pI 7.94

Acidic residues 1

Basic residues 3

Polar residues 4

Molecular weight (Average) 1304.49

Molecular weight (Monoisotopic) 1303.65

Common amino acids RT

Net charge 2

Instability index (II) -1.07

Aliphatic index 61.82

Grand average of hydropathicity (GRAVY) -0.382

Half Life
7.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all pairs of Cys residues form cystines
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID WO2011/060393A1

Patent Title Antimicrobial, Antiviral, Anticancer and Immunomodulatory Peptides and Uses Therefore

Other Iinformation Patent Application; Family: 1s / 1ex; Family Jurisdictions: WO; Legal Status: Pending; Application No: 2010056763; Filed: Nov 15, 2010; Published: May 19, 2011; Earliest Priority: Nov 16, 2009

Other Published ID US20090261738P20091116